Detalhe da pesquisa
1.
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
N Engl J Med
; 2024 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38828984
2.
Author Correction: Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin.
Nature
; 566(7745): E10, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742076
3.
Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin.
Nature
; 565(7739): 366-371, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30598548
4.
3D-SARC: A Pilot Study Testing the Use of a 3D Augmented-Reality Model with Conventional Imaging as a Preoperative Assessment Tool for Surgical Resection of Retroperitoneal Sarcoma.
Ann Surg Oncol
; 2024 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38898325
5.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129464
6.
Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma.
Ann Surg Oncol
; 29(12): 7297-7311, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088426
7.
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
Ann Surg Oncol
; 29(12): 7335-7348, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767103
8.
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Ann Surg Oncol
; 29(6): 3694-3708, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089452
9.
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
Australas J Dermatol
; 63(1): 43-52, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751431
10.
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study.
Australas J Dermatol
; 63(3): 344-351, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486539
11.
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Cancer
; 127(13): 2251-2261, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826754
12.
Tumor reactivity of CD8+ T cells favors acquisition of dysfunctional states in human melanoma.
Immunol Cell Biol
; 99(9): 914-916, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545624
13.
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.
Ann Surg Oncol
; 28(12): 7873-7888, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852100
14.
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group.
Ann Surg Oncol
; 28(11): 6882-6889, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740198
15.
A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.
J Surg Oncol
; 124(8): 1544-1550, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406652
16.
The role of 18 F-FDG PET/CT in retroperitoneal sarcomas-A multicenter retrospective study.
J Surg Oncol
; 123(4): 1081-1087, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33444466
17.
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy.
J Surg Oncol
; 123(1): 117-126, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33084061
18.
Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
J Surg Oncol
; 123(4): 1057-1066, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368277
19.
Patient-reported outcomes in melanoma survivors at 1, 3 and 5 years post-diagnosis: a population-based cross-sectional study.
Qual Life Res
; 29(8): 2021-2027, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140919
20.
Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
Semin Immunol
; 28(1): 64-72, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26611350